Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease (Q29994860)

27 June 2017

Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease (English)

1 reference

27 June 2017

1 reference

Satoka Kasai

1

1 reference

27 June 2017

Toru Yoshihara

2

1 reference

27 June 2017

Olga Lopatina

3

1 reference

27 June 2017

Katsuhiko Ishihara

4

1 reference

27 June 2017

Haruhiro Higashida

5

1 reference

27 June 2017

3 May 2017

1 reference

Frontiers in Behavioral Neuroscience

27 June 2017

1 reference

27 June 2017

11

1 reference

27 June 2017

75

1 reference

Stages in the development of Parkinson's disease-related pathology

27 June 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Stress and the brain: from adaptation to disease

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

CD157 is an important mediator of neutrophil adhesion and migration

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Cortical-Subcortical Interactions in Depression: From Animal Models to Human Psychopathology

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Parkinson's disease: clinical features and diagnosis

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

The molecular neurobiology of depression

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Allostasis and allostatic load: implications for neuropsychopharmacology

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Human BST-1 expressed on myeloid cells functions as a receptor molecule

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

CD38 and CD157: a long journey from activation markers to multifunctional molecules

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Therapies for depression in Parkinson's disease

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

The dopamine metabolite 3-methoxytyramine is a neuromodulator

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Mirtazapine versus other antidepressive agents for depression

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

22 May 2017

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator.

22 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Association Study between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Lipo-oxytocin-1, a Novel Oxytocin Analog Conjugated with Two Palmitoyl Groups, Has Long-Lasting Effects on Anxiety-Related Behavior and Social Avoidance in CD157 Knockout Mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

CD157 at the intersection between leukocyte trafficking and epithelial ovarian cancer invasion.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

NAD⁺ metabolism: a therapeutic target for age-related metabolic disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Large-scale replication and heterogeneity in Parkinson disease genetic loci

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Genetics of Parkinson's disease and essential tremor

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Genome-wide association study confirms extant PD risk loci among the Dutch

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Functional role and prognostic significance of CD157 in ovarian carcinoma.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Neuroanatomy and pathology of sporadic Parkinson's disease.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Anxiety rating scales in Parkinson's disease: critique and recommendations

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Non-motor symptoms of Parkinson's disease: diagnosis and management

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Stress, cognitive impairment and cell adhesion molecules

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

The corticosteroid receptor hypothesis of depression

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

BST-1/CD157 regulates the humoral immune responses in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Stress and emotionality: a multidimensional and genetic approach

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

The behavioural effects of pramipexole, a novel dopamine receptor agonist

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Genomic structure of human BST-1.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Movement disorders associated with the serotonin selective reuptake inhibitors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Molecular cloning of murine BST-1 having homology with CD38 and Aplysia ADP-ribosyl cyclase

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Psychiatric aspects in Parkinsonism treated with L-dopa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Does levodopa alter depression and psychopathology in Parkinsonism patients?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Specificity of affective and autonomic symptoms of depression in Parkinson's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Depression and Parkinson's disease: a review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Behavioral despair in mice: a primary screening test for antidepressants

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5413561

Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse.

3 June 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Depression in Parkinsonʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Depression and Parkinson's disease: a new look at an old problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Abnormal amygdala function in Parkinson's disease patients and its relationship to depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Effects of antidepressants in the rat forced swimming test.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Analysis of genome-wide association study-linked loci in Parkinson's disease of Mainland China

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Antidepressant-like effects of selegiline in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

A validation study of depressive syndromes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2017.00075

21 January 2018

1 reference

12 December 2020

Symptomatic effect of selegiline in de novo Parkinsonian patients. The French Selegiline Multicenter Trial

1 reference

12 December 2020

L-deprenyl plus L-phenylalanine in the treatment of depression

1 reference

12 December 2020

Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice

1 reference

12 December 2020

Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250")

1 reference

12 December 2020

Deletion of bone marrow stromal cell antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses

1 reference

12 December 2020

L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression

1 reference

12 December 2020

Depressive symptoms in Parkinson's disease

1 reference

12 December 2020

Amygdalectomy Inhibits Adrenocortical Responses to Somatosensory and Olfactory Stimulation

1 reference

12 December 2020

Identifiers

DOI

10.3389/FNBEH.2017.00075

1 reference

27 June 2017

0 references

1 reference